NASDAQ:OABI OmniAb (OABI) Stock Price, News & Analysis $4.84 +0.04 (+0.83%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$4.76▼$4.9650-Day Range$3.65▼$4.8452-Week Range$3.56▼$6.72Volume405,899 shsAverage Volume554,917 shsMarket Capitalization$569.26 millionP/E RatioN/ADividend YieldN/APrice Target$9.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get OmniAb alerts: Email Address OmniAb MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside86.0% Upside$9.00 Price TargetShort InterestBearish8.84% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.07Based on 6 Articles This WeekInsider TradingAcquiring Shares$1.06 M Bought Last QuarterProj. Earnings GrowthGrowingFrom ($0.66) to ($0.44) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.89 out of 5 starsMedical Sector662nd out of 936 stocksCommercial Physical Research Industry8th out of 12 stocks 3.5 Analyst's Opinion Consensus RatingOmniAb has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageOmniAb has only been the subject of 1 research reports in the past 90 days.Read more about OmniAb's stock forecast and price target. Previous Next 0.0 Short Interest Percentage of Shares Shorted8.84% of the float of OmniAb has been sold short.Short Interest Ratio / Days to CoverOmniAb has a short interest ratio ("days to cover") of 12.7, which indicates bearish sentiment.Change versus previous month Previous Next 0.0 Dividend Strength Dividend YieldOmniAb does not currently pay a dividend.Dividend GrowthOmniAb does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for OABI. Previous Next 2.3 News and Social Media Coverage News SentimentOmniAb has a news sentiment score of 0.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for OmniAb this week, compared to 2 articles on an average week.Search Interest4 people have searched for OABI on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added OmniAb to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, OmniAb insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,060,800.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 8.60% of the stock of OmniAb is held by insiders.Percentage Held by Institutions72.08% of the stock of OmniAb is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about OmniAb's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for OmniAb are expected to grow in the coming year, from ($0.66) to ($0.44) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of OmniAb is -7.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of OmniAb is -7.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOmniAb has a P/B Ratio of 1.80. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about OmniAb's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 MediaNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has led to a massive bull run in the year after it happens. That means we're in the "golden window" right now…Check out the new "Crypto Bull Run Millionaire Blueprint" now! About OmniAb Stock (NASDAQ:OABI)OmniAb, Inc., a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company's technology platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic, a bispecific rat, and OmniClic, a bispecific chicken, designed for discovery of bispecific antibody applications; OmniTaur, which provides unique structural characteristics of cow antibodies for complex targets; and OmniDeep, a suite of in silico, an AI and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California.Read More OABI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OABI Stock News HeadlinesJuly 25 at 9:15 PM | finance.yahoo.comOmniAb to Report Second Quarter 2024 Financial Results on August 8July 22, 2024 | americanbankingnews.comBrokers Set Expectations for OmniAb, Inc.'s FY2024 Earnings (NASDAQ:OABI)July 27, 2024 | American Hartford Gold Group (Ad)Dave Ramsey Makes Big Mistake Live On AirDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.May 20, 2024 | businesswire.comOmniAb to Participate in the Jefferies Global Healthcare ConferenceMay 16, 2024 | markets.businessinsider.comCraig-Hallum Reaffirms Their Buy Rating on OmniAb (OABI)May 15, 2024 | businesswire.comOmniAb Presents High-Throughput Single B-cell Screening xPloration® Data at the 20th Annual PEGS Boston SummitMay 12, 2024 | finance.yahoo.comOmniAb, Inc. (NASDAQ:OABI) Q1 2024 Earnings Call TranscriptMay 11, 2024 | au.investing.comEarnings call: OmniAb Inc. Q1 2024 financial results and updatesJuly 27, 2024 | American Hartford Gold Group (Ad)Prepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.May 11, 2024 | finance.yahoo.comOmniAb First Quarter 2024 Earnings: Misses ExpectationsMay 11, 2024 | finance.yahoo.comWe're Keeping An Eye On OmniAb's (NASDAQ:OABI) Cash Burn RateMay 11, 2024 | markets.businessinsider.comTruist Financial Keeps Their Buy Rating on OmniAb (OABI)May 9, 2024 | investorplace.comOABI Stock Earnings: OmniAb Misses EPS, Misses Revenue for Q1 2024May 9, 2024 | seekingalpha.comOmniAb, Inc. 2024 Q1 - Results - Earnings Call PresentationMay 9, 2024 | businesswire.comOmniAb Reports First Quarter 2024 Financial Results and Business HighlightsMay 1, 2024 | businesswire.comOmniAb to Participate in Five Investor Conferences in MayApril 22, 2024 | finance.yahoo.comOmniAb to Report First Quarter 2024 Financial Results on May 9April 22, 2024 | businesswire.comOmniAb to Report First Quarter 2024 Financial Results on May 9See More Headlines Receive OABI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OmniAb and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/09/2024Today7/27/2024Next Earnings (Confirmed)8/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Commercial physical research Sub-IndustryBusiness Services Current SymbolNASDAQ:OABI CUSIPN/A CIK1846253 Webwww.omniab.com Phone510-250-7800FaxN/AEmployees7Year FoundedN/APrice Target and Rating Average Stock Price Target$9.00 High Stock Price Target$11.00 Low Stock Price Target$7.00 Potential Upside/Downside+86.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($0.64) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-50,620,000.00 Net Margins-301.62% Pretax Margin-374.48% Return on Equity-19.93% Return on Assets-16.65% Debt Debt-to-Equity RatioN/A Current Ratio4.38 Quick Ratio4.38 Sales & Book Value Annual Sales$21.05 million Price / Sales27.05 Cash FlowN/A Price / Cash FlowN/A Book Value$2.69 per share Price / Book1.80Miscellaneous Outstanding Shares117,615,000Free Float107,500,000Market Cap$569.26 million OptionableOptionable Beta-0.12 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Matthew W. Foehr (Age 51)President, CEO & Director Comp: $967.72kMr. Kurt A. Gustafson (Age 56)Executive VP of Finance & CFO Comp: $558.48kMr. Charles S. Berkman J.D. (Age 55)Chief Legal Officer & Secretary Comp: $734.33kMs. Cia McCaffreyVice President of People & TalentDr. Bill Harriman Ph.D.Senior Vice President of Antibody DiscoveryMs. Marie-Cecile van de Lavoir D.V.M.Ph.D., Senior Vice President of Technical Operations & GeneticsDr. Christel Iffland Ph.D.Senior Vice President of Antibody TechnologiesDr. Douglas S. Krafte Ph.D. (Age 66)Senior VP of Ion Channels/Transporters & Icagen Ion Channel Technology Site Head Ms. Donna Ventura CPASenior Vice President of Corporate ControllerMore ExecutivesKey CompetitorsCorsair PartneringNYSE:CORSDTRT Health AcquisitionNASDAQ:DTRTDirect Selling AcquisitionNYSE:DSAQGood Works II AcquisitionNASDAQ:GWIIWilliams Rowland AcquisitionNYSE:WRACView All CompetitorsInsiders & InstitutionsTowerview LLCBought 285,000 shares on 7/26/2024Ownership: 0.455%Bank of New York Mellon CorpSold 26,206 shares on 7/26/2024Ownership: 0.338%Allspring Global Investments Holdings LLCSold 4,458 shares on 7/26/2024Ownership: 0.064%SG Americas Securities LLCSold 19,495 shares on 7/12/2024Ownership: 0.014%Simplicity Wealth LLCBought 7,976 shares on 7/10/2024Ownership: 0.036%View All Insider TransactionsView All Institutional Transactions OABI Stock Analysis - Frequently Asked Questions How have OABI shares performed this year? OmniAb's stock was trading at $6.17 at the beginning of 2024. Since then, OABI stock has decreased by 21.6% and is now trading at $4.84. View the best growth stocks for 2024 here. How were OmniAb's earnings last quarter? OmniAb, Inc. (NASDAQ:OABI) posted its earnings results on Thursday, May, 9th. The company reported ($0.19) EPS for the quarter, missing analysts' consensus estimates of ($0.17) by $0.02. The business earned $3.80 million during the quarter, compared to analyst estimates of $6 million. OmniAb had a negative trailing twelve-month return on equity of 19.93% and a negative net margin of 301.62%. Who are OmniAb's major shareholders? OmniAb's top institutional shareholders include Towerview LLC (0.45%), Bank of New York Mellon Corp (0.34%), Allspring Global Investments Holdings LLC (0.06%) and Simplicity Wealth LLC (0.04%). Insiders that own company stock include Kurt A Gustafson and Jennifer R Cochran. View institutional ownership trends. How do I buy shares of OmniAb? Shares of OABI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:OABI) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OmniAb, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OmniAb With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OABI Stock Alerts